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E-mail address: bjpharvey@rcsi.ie (B.J. Harvey).Estrogen, 17b-estradiol (E2), has been shown to modulate the activity of ion channels in a diverse range
of epithelial tissues. The channel activation or inhibition responses to E2 are often rapid, occurring in sec-
onds to minutes, independent of protein synthesis and gene transcription (‘non-genomic’ response).
These rapid effects of E2 require activation of speciﬁc protein kinases or changes in intracellular calcium
and pH which in turn modulate the conductance, open probability or number of channels in the plasm-
amembrane. Estrogen has also been shown to affect the expression of ion transporters over days (‘geno-
tropic’ response) causing long-term sustained changes in transepithelial ion transport. It is now accepted
that so called non-genomic responses are not stand-alone events and are necessary to prime the latent
genomic response and even be critical for the full latent response to occur. In a number of epithelia
the non-genomic and genotropic responses to estrogen are sex-speciﬁc and variable in potency and sen-
sitivity to E2 depending on the stage of the estrous cycle. Of increasing interest is the effect these rapid
and latent actions of E2 on ion transporters have on the physiological functions of epithelia. For example,
estrogen regulation of a class of voltage-gated K+ channels (KCNQ1) can determine the rate of Cl secre-
tion in the intestine. In whole-body terms, the combined effects of estrogen on a variety of ion channels
which control ﬂuid and electrolyte transport in the kidney, intestine and lung may be necessary for endo-
metrial expansion and implantation of the blastocyte.
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The physiology and pathophysiology of estrogen effects on ion
channels and transporters in epithelial tissues is of topical interest.ll rights reserved.
odium Channel; CCD, cortical
Molecular Medicine, Royal
Research Centre, Beaumont
53 1 8093817; fax: +353 1Epithelial ion channels play a critical role in the maintenance of
whole body ﬂuid balance and in the progression of common
diseases such as secretory diarrhea and cancer cell proliferation.
The extra-gonadal effects of estrogen on ion channels and trans-
porters are female-sex speciﬁc and both rapid ‘non-genomic’ and
genomic in their cell signaling patterns. In healthy tissues, estrogen
modulation of ion channel activity and transporters appear to have
beneﬁcial effects. For example, estrogen produces a rapid onset
and sustained anti-secretory response in intestinal epithelia by
inhibiting chloride ion secretion via inactivation of KCNQ1:KCNE3
channels (Fig. 1). The positive effects on organ physiology may be
Fig. 1. Actions of 17b-estradiol (E2) on ion channels in distal colon, airway and renal epithelia. In the colon, E2 activates PKCd leading to a decrease in K+ efﬂux through the
basolateral KCNQ1:KCNE3 channel. As K+ recycling provides the driving force for Cl secretion, E2 inhibits this process, preventing diarrhea in the cases of infection by V.
cholerae or E. coli. In the airways, E2 dehydrates the airway surface liquid through the activation of PKCd and an increase in Na+ absorption via ENaC, impairing mucociliary
clearance and therefore exacerbating the lung pathophysiology in patients with cystic ﬁbrosis. As in the airways, E2 targets PKCd and ENaC to increase Na+ absorption in the
kidney, showing that E2 is an important player in the regulation of the electrolyte and ﬂuid transport in this organ.
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cellular ﬂuid (ECF) volume needs to be conserved (for example dur-
ing blastocyst implantation into the swollen endometrium).
Reproductive females experience the inconvenience of ﬂuid reten-
tion during high estrogen states in mid-estrus cycle and ‘bloating’
or excessive ﬂuid retention is a common feature of estrogen treat-
ment in assisted fertilization. It has been postulated that the anti-
secretory effects of estrogen in the intestine contribute to ECF vol-
ume expansion during the implantation window [1]. Such an effect
may be short-circuited by compensatory Na+ and water excretory
mechanisms in the kidney or insensible transpiration in the lung.
However, estrogen exerts pro-absorptive effects in bronchial air-
way epithelium and in kidney cortical collecting duct cells by rap-
idly activating ENaC and transepithelial Na+ absorption (Fig. 1).
Thus the major ECF regulatory organs contribute to the overall
physiological response to estrogen, causing ECF expansion to per-
mit implantation (Fig. 1). The deleterious consequences of estrogen
action on epithelial ion channels appears to be conﬁned to diseased
tissues where ion absorption/secretion is already compromised
such as the airways in cystic ﬁbrosis or in breast cancer where
ion channel activation may amplify proliferative signals. Thus for
example, the inﬂuence of estrogen on ion channel activity in epi-
thelia may change the course of a disease, such as in the gender
gap of cystic ﬁbrosis where the pro-absorptive and anti-secretory
effects of estrogen can reduce airway ﬂuid dynamics thus exacer-
bating mucociliary clearance and lung function (Fig. 1). We are cur-
rently at the pioneering stage of understanding estrogen actions on
ion channels and transporters in general and the consequences in
health and disease. Much is yet to be uncovered in the underlying
physiology and molecular mechanisms of rapid estrogen responses
in epithelia, in particular, with respect to the sexual dimorphism of
extra-gonadal effects of estrogen on ion channels. In this reviewwe
focus on estrogen and ion channels in kidney, lung and intestinal
epithelia, in health and disease, giving an insight into the current
state-of-the-art as well as promising areas for future research.2. Estrogen regulation of ion transport in the kidney
One of the main physiological functions attributed to the kidney
is the regulation of water and electrolyte content of the body. This
function is performed by its basic structural and functional unit,
the nephron. In the distal nephron, the cortical collecting duct
(CCD) plays a critical role in the hormonal control of electrolyte
and ﬂuid homeostasis and it has been shown that these processes
can be tightly regulated by the hormones insulin, vasopressin and
aldosterone [2–12]. The rapid non-genomic actions of aldosterone
on renal ion transporters has been well-described [13–18]. Aldo-
sterone regulates CCD Na+ reabsorption in a rapid non-genomic
and genomic manner; this regulation involves changes in Epithelial
Sodium Channel (ENaC) expression, trafﬁcking dynamics, stability
at the plasma membrane and changes in open channel probability
[29–31].
For many years, it has been shown that 17b-estradiol (E2) has
an impact in the control of whole body electrolyte and ﬂuid
homeostasis [19–22], however, it is only in the last decade that
the targets and molecular mechanisms involved in this regulation
have started to be identiﬁed [23–25]. The kidney has been pro-
posed as an estrogen-responsive target where E2 could exert a
pro-absorptive effect [23]. Moreover, a possible role of E2 in stim-
ulation of renal K+ secretion [24], Ca2+ signaling [15,25,26], pH
homeostasis [27] and the rennin–angiotensin pathway [28] has
been proposed.
Evidence suggesting a long-term sex-speciﬁc pro-absorptive ef-
fect for E2 in the kidney have been published in recent years
[32,33]. In rat kidney, it has been shown that the abundance of
a-, b- and c-ENaC subunit mRNA was signiﬁcantly higher in female
compared to male rat kidneys. These sex differences were abol-
ished in ovariectomized rats and treatment of ovariectomized rats
with E2 increased renal a-ENaC subunit mRNA levels over long
periods up to 24 h [32]. Another study, in a diabetic rat model,
has shown that E2 causes diabetes dependent and independent
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proteins [33]. In mouse collecting tubular cells, E2 or progesterone
alone increased ENaC activity and a low concentration of E2
together with progesterone produced an additive stimulation of
ENaC activity [34]. Ovariectomized female rats treated with E2 also
showed an increase in plasma Na+ concentration [35]. Further-
more, this study has shown that in aldosterone-infused female
rats, plasma Na+ was increased further than in male rats infused
with aldosterone [35], suggesting a regulatory role for E2 on the
renin–angiotensin–aldosterone system (RAAS) [28].
The evidence described above involves only long-term effects
for E2 on Na+ reabsorption and, in contrast, little is known about
the E2 short-term effects on renal transport processes. Recently,
we have found evidence for a rapid E2 pro-absorptive effect in
the distal nephron via stimulation of ENaC activity. The rapid E2
activation (<15 min) of amiloride-sensitive Na+ current in mouse
M1 CCD cells was sensitive to inhibitors of PKCd and ERa (Yusef
& Harvey, unpublished).
As for the case of Na+ reabsorption, K+ secretion in the kidney
can be tightly regulated by aldosterone. The classical mechanism
involves an increase in the expression of the Na+/K+-ATPase at
the basolateral membrane of principal cells of the CCD and a sub-
sequent increase in the driving force for K+ secretion through the
Renal Outer Medullary Potassium channel (ROMK) [36]. A second
and more novel mechanism is related to situations of high plasma
K+ concentration where an increase of plasma aldosterone leads to
repression of signaling pathways involved in the inhibition of api-
cal K+ channels such as ROMK and BK [25]. However, a possible
regulation of K+ secretion by E2 in the kidney has not been estab-
lished. Inspired by the observation that polycystic kidney disease
has worse prognosis in men, a study performed in MDCK cells
has shown that testosterone stimulates ﬂuid secretion by increas-
ing cAMP levels but failed in showing any effect for E2 [37]. On the
other hand, a more recent study has shown that in aldosterone-in-
fused female rats, plasma K+ concentration was reduced further
than in male rats infused with aldosterone. Furthermore E2 but
not progesterone reduced plasma K+ concentration in ovariecto-
mized female rats [35]. These observations provide another piece
of evidence supporting a possible regulatory effect of E2 on RAAS.
In recent years data supporting a novel role for E2 to rapidly
regulate Ca2+ homeostasis in the kidney has been shown
[25,26,38]. E2 can rapidly modulate intracellular Ca2+ levels
through a Ca2+ entry pathway in kidney M1 cells [15]. Moreover,
it has been shown that TRPV5, a Ca2+-permeable cation channel
member of the Transient Receptor Potential channel subfamily, is
responsible for the rapid and transient increase in whole-cell cur-
rents and intracellular Ca2+ concentration ([Ca2+]i) induced by E2 in
rat CCD cells [26]. A more recent study has shown acute actions of
E2 on intracellular Ca2+ signaling in intercalated cells from isolated
distal convoluted tubules, connecting tubules and initial cortical
collecting ducts [27]. It has been postulated that the E2 induced
[Ca2+]i increases and enhanced H+-ATPase activity may occur
through the activation of the membrane associated estrogen recep-
tor, GPER1 [27].
Although the current literature is scarce on E2 regulation of kid-
ney ion transport recent evidence points to a previously unknown
role of E2 as an important player in the regulation of the electrolyte
and ﬂuid transport in the kidney, its potential role in the regulation
of RAAS and a non-genomic regulation of ENaC.3. Estrogen regulation of ion transport in airway epithelium
The epithelium lining the lung is covered by a thin layer of ﬂuid
that provides a barrier against inhaled pathogens and particles. In
the bronchi, the airway surface liquid (ASL) covers the bronchialepithelial cells and is composed of two layers. The periciliary layer
has a low viscosity to allow beating cilia remove inhaled particles
and pathogens which are trapped in the second layer, the mucus.
The hydration of ASL and its height at 10 lm have to be optimal
for an efﬁcient mucociliary clearance [39]. The transepithelial
movement of Cl, Na+ and K+ are mainly responsible for the trans-
port of water and therefore the hydration of the ASL. As in other
epithelia, Na+ is transported from the apical surface to the blood
via apical membrane ENaC and the basolateral Na+/K+-ATPase.
The recycling of K+ through potassium-selective ion channels
across the basolateral membrane provides the driving force for
Cl secretion across the apical membrane. Cl is secreted from
the basolateral to the apical side through the Na+/K+/2Cl co-
transporter and apical Cl channels such as the cystic ﬁbrosis
transmembrane conductance regulator (CFTR) or Ca2+-dependent
Cl channels such as TMEM16A.
The pulmonary epithelium is a target for steroid hormones and
their effects on lung function, inﬂammation or immune responses
to allergen exposure have been studied in depth. Estrogen has been
shown to modulate the innate immune response in the lung. Cystic
ﬁbrosis mice when injected with estrogen and then infected with
Pseudomonas aeruginosa, increased the number of white blood cells
and PMN (polymorpho nuclear neutrophils) in the whole lung and
in the broncho-alveolar lavage. E2 exposure in the lung of CF mice
increased the inﬂammatory inﬁltrate, mucin and the mRNA levels
of Toll Like Receptor 2, InterLeukin (IL)-23 and IL-17A [40]. In the
case of allergen exposure in the lung, E2 may have a beneﬁcial ef-
fect. Indeed, male mice, nebulised with ovalbumin for 10 days and
then challenged with methacholine, developed airway hyper-
responsiveness whereas female mice undergoing the same proto-
col did not show a hyperactive airway [41]. In relation to asthmatic
responses it has also been described that E2 could prevent the cho-
linergic constriction of tracheal rings [42].
In contrast, little is known about the effect of female hormones
on airway epithelial ion transport. The few published studies show
that estrogen may modulate ion transport in airway epithelial cells
and that this can have beneﬁcial or deleterious effects depending
on the tissue compartment and on the physiology/pathophysiology
state of the airway. For example, it has been described that after an
episode of respiratory distress syndrome (RDS), female patients
show a much more efﬁcient airway ﬂuid clearance as well as a
higher survival rate [43]. It has also been shown that preterm ba-
bies have a much lower plasma concentration of estrogen and pro-
gesterone and that the infants given estrogen supplement have less
severe RDS and improved survival [44]. These studies suggest a
role for female hormones in airway ﬂuid clearance and lung devel-
opment. This conclusion is strengthened by a study in newborn
piglets that prenatal estrogen and progesterone deprivation, by
the use of speciﬁc estrogen and progesterone receptor antagonists,
impaired the formation of the alveolar compartments and de-
creased the amiloride sensitive airway ﬂuid clearance [45].
Thus it would appear that estrogen can affect Na+ reabsorption
and ﬂuid clearance in the lung. The ﬁrst study to indicate such a
role for E2 came from Sweezey et al. in 1998 showing an increase
in ENaC activity and mRNA copies in isolated alveolar type II epi-
thelial cells [46]. A later study by Laube et al. described that a cock-
tail of estrogen and progesterone increased basal short-circuit
current as well as amiloride- and ouabain-sensitive currents in
alveolar epithelial cells. This study also showed that these hor-
mones increased the mRNA expression levels of a- and b-ENaC
subunits and the Na+/K+-ATPase b1 subunit [44]. These results fur-
ther indicate a regulatory role for female sex hormones on Na+
absorption in airway epithelium with a physiological consequence
for alveolar airway ﬂuid clearance.
Although estrogen may have beneﬁcial effects on innate im-
mune responses in allergic asthma and on ﬂuid clearance in RDS,
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in chronic pulmonary diseases is not straight-forward [47]. In some
chronic inﬂammatory lung diseases such as cystic ﬁbrosis (CF),
estrogen is reported to exacerbate lung function – the so-called
CF gender gap. Moreover, it has been described that lung function
changes with the menstrual cycle phase in women with CF [48].
The amiloride-insensitive nasal potential difference (NPD) was
found to be increased in CF female patients during the luteal phase
(high estrogen + progesterone concentration) of the menstrual cy-
cle when compared to the follicular phase [49], probably due to an
altered transepithelial Na+ absorption. Other groups have studied
the effect of estrogen on Cl transport in CF female patients and
in CF bronchial epithelial cell lines. Fanelli et al. showed an in-
crease of Cl efﬂux in the CF bronchial epithelial cell line CFBE41o-
after 17b-estradiol treatment. This effect was due to an increase in
F508del-CFTR in the apical membrane through the up-regulation
of NHERF1 [50]. In 2008, Coakley et al., showed a decrease in
UTP induced nasal potential difference variation during high estro-
gen blood levels in CF and non-CF female patients [51]. From this
observation, they studied the effect of estrogen on nucleotide-
mediated ASL regulation and found that E2 decreased Ca2+ signal-
ing and impaired ASL volume homeostasis through the estrogen
receptor ERa. A recent study has shown a compromised IL-8 re-
sponse in inﬂammation with estrogen treatment in CF bronchial
epithelium [52]. Taken together, these studies in bronchial and
alveolar epithelia indicate a physiological role for sex-speciﬁc ac-
tions of estrogen on airway ion transport and ﬂuid clearance in
the normal lung and a pathophysiological role in exacerbation of
lung function in cystic ﬁbrosis.4. Estrogen regulation of ion transport in intestinal epithelium
The large intestine plays a major role in regulation of whole-
body water and salt homeostasis. The distal colon is the main site
for water conservation in the body. Every day 1–1.5 l of ﬂuid enters
the colon with only 0.1–0.2 l being lost in the feces under normal
conditions. This ﬂuid movement is supported by two transport
processes: Na+ absorption and Cl secretion. Na+ absorption
through the Na+/H+ exchanger NHE1 in the small intestine and
via ENaC in the colon permits the absorption of water from the
feces under physiological conditions. ENaC in the intestine is acti-
vated by aldosterone or low plasma Na+. This channel constitutes
the electrogenic pathway for intestinal Na+ absorption regulated
by steroid hormones. The colonic epithelium is a major site for
neurohumoral regulated Cl secretion, which serves to ensure
the mucosal hydration and the lubriﬁcation necessary for the pas-
sage of the fecal matter through the colon. Cl secretion is a com-
plex mechanism involving different ion channels and transporters.
Cl is transported into the cell basolaterally through the Na+/K+/
2Cl co-transporter NKCC1 and is secreted across the apical mem-
brane through the cystic ﬁbrosis transmembrane conductance reg-
ulator (CFTR). The electrochemical driving force for Cl secretion is
provided by K+ recycling across the basolateral membrane via two
types of channels, KCNN4 and KCNQ1 potassium channels. Cl
secretion may be activated by two different pathways. The
cAMP-mediated Cl secretion is activated by secretagogues that in-
crease intracellular cAMP levels which also activate KCNQ1:KCNE3
channels. The calcium mediated Cl secretion is activated follow-
ing a rise in intracellular calcium and a stimulation of calcium-
dependent apical Cl channels and basolateral KCNN4 channels
[53]. Interestingly, estrogen has been described as a salt retaining
steroid hormone, high estrogen states produce an increase in
whole body ﬂuid and salt retention. Moreover distal colon has been
identiﬁed as a target tissue for 17b-estradiol; indeed colonic crypts
express both estrogen receptor isoforms, ERa and ERb [54]. Ourlaboratory ﬁrst described the inhibitory role of estrogen on
epithelial Cl secretion in the female distal colonic crypts [55].
The anti-secretory response to estrogen in the intestine occurs in
a sex speciﬁc manner, no effects on secretion were found in male
rats, and estradiol inhibited both basal and secretagogue-induced
Cl secretion in female rats. The potency of the E2 anti-secretory
response varied with the stage of estrous cycle and was rapid in
onset, non-genomic and involved the activation of speciﬁc PKC
isoforms [56,57]. This study established a physiological role for
estrogen as a regulator of Cl secretion in order to contribute to
the E2-induced salt and water retention observed during the high
estrogen states [58].
4.1. Estrogen regulation of KCNQ1:KCNE3 potassium channels
Studies from our laboratory have determined the molecular
mechanisms for E2 inhibition of Cl secretion via the modulation
of KCNQ1:KCNE3 potassium channels in the basolateral membrane
[59]. KCNQ1 is a voltage-gated K+ channel expressed in a wide
range of tissues and can associate with the KCNE family of regula-
tory subunits, which is made up of ﬁve isoform members. The
expression of KCNE isoforms is tissue speciﬁc. The association be-
tween KCNQ1 and a speciﬁc KCNE subunit can drastically change
the electrophysiological properties of the channel [60]. For exam-
ple KCNQ1 expressed with KCNE1 produces the delayed rectiﬁer
channel expressed in the heart and essential for the cardiac action
potential repolarization. In the distal colon, KCNQ1 is expressed
with KCNE3 and this association causes KCNQ1 to function as a
constitutively activated K+ channel. This electrophysiological char-
acteristic ﬁts with the function of KCNQ1 in epithelial cell K+ recy-
cling [61]. The molecular mechanisms leading to KCNQ1 inhibition
by estrogen involves PKCd and PKACI activation, and subsequent
KCNE3 phosphorylation and dissociation from KCNQ1 causing a ra-
pid decrease in channel conductance [56]. The sexual dimorphism
in the E2 response can be explained, at least in part, by the higher
expression of PKCd in female than in the male tissue. Moreover
PKCd and PKA expression were shown to ﬂuctuate throughout
the estrous cycle with a correlation between high levels of protein
kinase expression and the potency of the anti-secretory effect of E2
[57]. Thus it appears that KCNE3 plays a critical role in the sex-spe-
ciﬁc actions of estrogen on epithelial Cl secretion. In colonocytes
KCNE3 increases KCNQ1 channel open probability at the resting
membrane potential and KCNE3 is more expressed in male tissue
than in female in which expression is also estrous cycle dependent.
When plasma E2 levels are high, KCNE3 expression is lower.
Importantly, the E2 effects on K+ channel subunit association ap-
pears to be speciﬁc to KCNQ1:KCNE3 and other channel subunit
isoform complexes are unaffected such as KCNE2 or KCNE1 associ-
ation with KCNQ1. This speciﬁcity should confer a tissue-speciﬁc
effect of estrogen on K+ channel activity in the intestine and airway
epithelia where KCNQ1:KCNE3 predominates, leaving the heart
channel KCNQ1:KCNE1 unaffected. Patch-clamp experiments in
CHO cells have demonstrated the molecular mechanism for E2
inhibition of KCNQ1:KCNE3 channel current via PKCd phosphoryla-
tion of KCNE3 at the S82 amino acid site [59] with the subsequent
uncoupling between KCNE3 and KCNQ1 leading to KCNQ1 inacti-
vation and loss of the electrochemical driving force for Cl
secretion.
The inhibition of intestinal Cl secretion in high estrogen states
may be a physiological protective response against secretory diar-
rhea during the estrous cycle. Secretory diarrhea results in exces-
sive loss of body ﬂuids causing life-threatening dehydration and
electrolyte imbalance. The main causes of secretory diarrhea in hu-
mans are toxins secreted by Vibrio cholerae toxin (CT) and Esche-
richia coli heat-stable enterotoxin (STa). These toxins stimulate
cAMP or cGMP production which leads to a pronounced and
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diol rapidly inhibits and even prevents Cl secretion induced by
the bacterial toxins CT and STa in female rat colonic crypts. The
E2 inhibition of toxin induced intestinal secretion occurs via sex-
speciﬁc PKCd dependent modulation of KCNQ1:KCNE3 channels
to reduce the driving force for Cl secretion [61].4.2. Estrogen regulation of TRPV6 calcium ion channels
Modulation of intracellular free calcium ion activity is a crucial
signal for initiation of many important processes including gene
transcription, cell growth and proliferation, neurotransmitter re-
lease [62]. Since the whole body Ca2+ homeostasis is dependent
on gastrointestinal Ca2+ uptake, it is essential to understand the
regulation of intestinal Ca2+ absorption [63]. In rat female colonic
crypt, E2 rapidly stimulates a calcium inﬂux through a non-
genomic mechanism. It has been shown that this effect was
gender-speciﬁc and mediated by PKC and PKA dependent signaling
pathways [64]. Further studies carried out in another model of
colonic epithelium, the T84 cell line, correlated this effect of E2
on Ca2+ inﬂux with the E2 modulation of the endogenous Transient
Receptor Potential Vaniloid 6 (TRPV6) channel. TRPV6 is an epithe-
lial Ca2+ channel strongly expressed in colonic epithelium and has
been proposed to be the molecular pathway for capacitative
calcium entry and to play a signiﬁcant role in intestinal Ca2+
absorption [65]. Using siRNA directed against TRPV6 it has been
demonstrated that TRPV6 is the molecular target for the E2 effect
on Ca2+ inﬂux in intestinal epithelium [66]. These studies taken
together suggest that estrogen is a major hormonal regulator of
intestinal Ca2+ intake as a result of TRPV6 channel modulation.5. Conclusions
Estrogen regulation of the epithelial Na+ channel in kidney cor-
tical collecting duct cells can mimic the effects of aldosterone to
enhance Na+ reabsorption, revealing previously unknown renal re-
sponses to estrogen (Fig. 1). In the lung, the combined pro-
absorptive action of E2 through the activation of ENaC and the
anti-secretory response cause a reduction in the volume of airway
surface liquid lining the bronchial epithelium. Such ion transport
responses to E2 in airway epithelia are female sex-speciﬁc and
may underlie the CF gender gap where females with cystic ﬁbrosis
have exacerbated lung function after puberty and during the mid-
estrous cycle when circulating plasma levels of E2 are highest
(Fig. 1). In the intestine, one of E2 main targets is KCNQ1:KCNE3
channel and its inhibition leads to a decrease in Cl secretion, thus
regulating whole body ﬂuid balance (Fig. 1). Extracellular ﬂuid vol-
ume expansion is a feature of high estrogen states such as occur in
mid-term of the menstrual cycle, use of oral contraceptives and as-
sisted in vitro fertilization. The pro-absorptive, anti-secretory
effects of estrogen may underlie this ECF volume expansion. The
physiological role of estrogen regulation of ion channels in epithe-
lia of kidney, intestine and lung which regulate whole body ﬂuid
and electrolyte balance may be to maintain endometrial expansion
necessary for implantation of the blastocyst and to enhance cardio-
vascular dynamics during pregnancy.Acknowledgments
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